Medicinal product name Ezaprev 0.088 mg tablets
Pharmaceutical form Tablet
Strength 0.088 mg 
Information from the MAH on shortages Not available
predicted availability date: not notified
Legal status Rx Prescription (Pr.)
Package leaflet MS Word document 01-02-2018
Summary of product characteristics MS Word document 01-02-2018
ATC code N04BC05 Anti-parkinson drugs

Important notice

Additional information regarding the use for persons aged 75+

If used as "ANTI-PARKINSON DRUGS"
SubstanceClassComment
PramipexolumCSuitable for older persons, with specific cautions. Sedative. Start therapy under specialist supervision. Reduce the dose in even moderate renal insufficiency. The most common adverse effects are orthostatic hypotension, gastrointestinal symptoms, drowsiness, hallucinations, confusion and sudden bouts of falling asleep. Take interactions into account, especially with antipsychotics.

Medicinal products (3)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers)
predicted availability date: not notified
currently no information on availability from any wholesaler N30
(0,088 mg)
PA/Al/PVC/Al blister    09-0159-01 Labelling text Labelling text Feb 1, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N100
(0,088 mg)
PA/Al/PVC/Al blister    09-0159-02 Labelling text Labelling text Feb 1, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N10
(0,088 mg)
PA/Al/PVC/Al blister    09-0159-03 Labelling text Labelling text Feb 1, 2018

Registration information

Marketing authorisation No. 09-0159
Date of authorisation Apr 30, 2009
MA valid until For unlimited time
Marketing authorisation holder, country Norameda UAB, Lithuania